MentalHealthDaily

D-Cycloserine Targets the NMDA Receptors to Enhance Synpatic Plasticity in Hippocampus (2024 Study)

In the complex and evolving field of neuroscience, the role of synaptic plasticity in psychiatric disorders has garnered significant attention. d-Cycloserine (DCS), a partial agonist of the N-methyl-D-aspartate receptor (NMDAR), emerges as a key player in potentially revolutionizing treatment approaches. Highlights: d-Cycloserine (DCS): Initially an antimicrobial agent, DCS is now known for its role as …

New Antidepressant GLYX-13 (Clinical Trials): Partial NMDA Receptor Agonist

by GLOOM

A new antidepressant chemically named “GLYX-13” was developed by the biotech company Naurex for individuals with treatment-resistant depression. It is currently in clinical trials as an antidepressant augmentation strategy, meaning it is used as an add-on to already approved treatments. However, most evidence would suggest that it works extremely well as a standalone treatment option. …

7 Natural Remedies For Schizophrenia To Help Reduce Symptoms

by GLOOM

In cases of schizophrenia, a severe mental illness characterized by delusions, hallucinations, lack of emotion, and social isolation, most individuals are treated by a psychiatrist with an atypical antipsychotic medication. Without getting too technical, these medications are thought to block receptors in the brain’s dopamine pathways to help reduce symptoms. Atypical antipsychotics were created with …